tetrahydropalmatine has been researched along with Peripheral Nerve Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Jiang, H; Li, L; Li, P; Ni, S; Song, F; Yi, Y; Zeng, S; Zhang, H; Zhou, H | 1 |
1 other study(ies) available for tetrahydropalmatine and Peripheral Nerve Diseases
| Article | Year |
|---|---|
L-tetrahydropalmatine reduces oxaliplatin accumulation in the dorsal root ganglion and mitochondria through selectively inhibiting the transporter-mediated uptake thereby attenuates peripheral neurotoxicity.
Topics: Animals; Antineoplastic Agents; Behavior, Animal; Berberine Alkaloids; Carrier Proteins; Dogs; Ganglia, Spinal; HEK293 Cells; HT29 Cells; Humans; Madin Darby Canine Kidney Cells; Mice; Mice, Inbred ICR; Mice, Nude; Mitochondria; Multidrug Resistance-Associated Protein 2; Organic Cation Transport Proteins; Organic Cation Transporter 2; Oxaliplatin; Peripheral Nervous System Diseases; Rats; Solute Carrier Family 22 Member 5; Symporters | 2021 |